Geneesmiddelenbeleid

This procedure concerns the Dutch government's input and written consultations regarding European Union medicines policy. It focuses on how the Netherlands contributes to the development and regulation of pharmaceuticals at the EU level to ensure healthcare quality. This affects pharmaceutical companies, healthcare providers, and patients by influencing how medicines are approved, priced, and made available across the European Union.